D-Dimer Levels in Combination with Clinical Risk Factors Can Effectively Predict Subsequent Thromboembolic Events in Patients with Atrial Fibrillation during Oral Anticoagulant Therapy

Publisher： Karger

E-ISSN： 1421-9751|117|1|31-36

ISSN： 0008-6312

Source： Cardiology, Vol.117, Iss.1, 2010-09, pp. : 31-36

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bleeding risk during oral anticoagulation therapy for atrial fibrillation

By Gallego Pilar   Lip Gregory Y. H.   Lane Deirdre A.  

EP-Europace, Vol. 15, Iss. 6, 2013-06 ,pp. : 773-774

Oxford University Press

Access to resources Recommend Favorite

Effect of Hyperthyroidism on the Hypercoagulable State and Thromboembolic Events in Patients with Atrial Fibrillation

By  

Cardiology, Vol. 127, Iss. 3, 2014-01 ,pp. : 176-182

Karger

Access to resources Recommend Favorite

Medical costs in the US of clinical events associated with oral anticoagulant (OAC) use compared to warfarin among non-valvular atrial fibrillation patients ≥75 and <75 years of age, based on the ARISTOTLE, RE-LY, and ROCKET-AF trials

By Deitelzweig Steve   Amin Alpesh   Jing Yonghua   Makenbaeva Dinara   Wiederkehr Daniel   Lin Jay   Graham John  

Journal of Medical Economics, Vol. 16, Iss. 9, 2013-09 ,pp. : 1163-1168

Informa Healthcare

Access to resources Recommend Favorite

Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation: insights from the RE‐LY trial

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 5, 2015-05 ,pp. : 699-707

John Wiley & Sons Inc

Access to resources Recommend Favorite

Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: The SAMURAI‐NVAF Study

By  

INTERNATIONAL JOURNAL OF STROKE, Vol. 10, Iss. 6, 2015-08 ,pp. : 836-842

John Wiley & Sons Inc

Access to resources Recommend Favorite